These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26501902)

  • 1. Using Bioluminescent Kinase Profiling Strips to Identify Kinase Inhibitor Selectivity and Promiscuity.
    Zegzouti H; Hennek J; Goueli SA
    Methods Mol Biol; 2016; 1360():59-73. PubMed ID: 26501902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioluminescent kinase strips: A novel approach to targeted and flexible kinase inhibitor profiling.
    Hennek J; Alves J; Yao E; Goueli SA; Zegzouti H
    Anal Biochem; 2016 Feb; 495():9-20. PubMed ID: 26628096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring Activity of Phosphoinositide Lipid Kinases Using a Bioluminescent ADP-Detecting Assay.
    Tai AW; Vidugiriene J
    Methods Mol Biol; 2016; 1360():75-85. PubMed ID: 26501903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.
    Davis MI; Auld DS; Inglese J
    Methods Mol Biol; 2016; 1360():47-58. PubMed ID: 26501901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Flexible Workflow for Automated Bioluminescent Kinase Selectivity Profiling.
    Worzella T; Butzler M; Hennek J; Hanson S; Simdon L; Goueli S; Cowan C; Zegzouti H
    SLAS Technol; 2017 Apr; 22(2):153-162. PubMed ID: 28095176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-Glo: A Bioluminescent and homogeneous ADP monitoring assay for kinases.
    Zegzouti H; Zdanovskaia M; Hsiao K; Goueli SA
    Assay Drug Dev Technol; 2009 Dec; 7(6):560-72. PubMed ID: 20105026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the utility of a bioluminescent ADP-detecting assay for lipid kinases.
    Vidugiriene J; Zegzouti H; Goueli SA
    Assay Drug Dev Technol; 2009 Dec; 7(6):585-97. PubMed ID: 20035616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the luminescent ADP-Glo assay to a standard radiometric assay for measurement of protein kinase activity.
    Sanghera J; Li R; Yan J
    Assay Drug Dev Technol; 2009 Dec; 7(6):615-22. PubMed ID: 20105027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an antibody-free ADP detection assay: ADP-Glo.
    Li H; Totoritis RD; Lor LA; Schwartz B; Caprioli P; Jurewicz AJ; Zhang G
    Assay Drug Dev Technol; 2009 Dec; 7(6):598-605. PubMed ID: 20059376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
    Christmann-Franck S; van Westen GJ; Papadatos G; Beltran Escudie F; Roberts A; Overington JP; Domine D
    J Chem Inf Model; 2016 Sep; 56(9):1654-75. PubMed ID: 27482722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Simple and robust automated kinase profiling platform using luminescent ADP accumulation technology.
    Larson B; Banks P; Zegzouti H; Goueli SA
    Assay Drug Dev Technol; 2009 Dec; 7(6):573-84. PubMed ID: 20059362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors.
    Bauer SM; Kubiak JM; Rothbauer U; Laufer S
    Methods Mol Biol; 2016; 1360():123-48. PubMed ID: 26501907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays.
    Schröder M; Chaikuad A
    STAR Protoc; 2021 Sep; 2(3):100717. PubMed ID: 34401783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
    Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
    Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of kinase inhibitor selectivity using a thermodynamics-based partition index.
    Cheng AC; Eksterowicz J; Geuns-Meyer S; Sun Y
    J Med Chem; 2010 Jun; 53(11):4502-10. PubMed ID: 20459125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bioluminescent kinase assays using substrate depletion and product formation.
    Tanega C; Shen M; Mott BT; Thomas CJ; MacArthur R; Inglese J; Auld DS
    Assay Drug Dev Technol; 2009 Dec; 7(6):606-14. PubMed ID: 20059377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System-based drug discovery within the human kinome.
    Bamborough P
    Expert Opin Drug Discov; 2012 Nov; 7(11):1053-70. PubMed ID: 22971083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A High-Throughput Radiometric Kinase Assay.
    Duong-Ly KC; Peterson JR
    Methods Mol Biol; 2016; 1360():87-95. PubMed ID: 26501904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase profiling assays: a technology review.
    Wang Y; Ma H
    Drug Discov Today Technol; 2015 Nov; 18():1-8. PubMed ID: 26723886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.